Canadian Medical Isotope Ecosystem

Check out the exciting results from the Canadian Medical Isotope Ecosystem's second call for proposals! We look forward to helping advance these new Canadian programs! 🍁

We're pleased to announce the results from our second call for proposals! Three outstanding medical isotope programs have been selected to receive a total of $1.48 million in funding through the Canadian Medical Isotope Ecosystem Development Fund (CMIEDF). Congratulations to Promation, RadioSyn, and RC14. Read our full press release here: https://lnkd.in/g7tWAXWC

We’re excited to announce the theme for the Canadian Radiotheranostics Leaders’ Summit 2025 – “Seizing the radioisotope opportunity from coast to coast”. We look forward to welcoming isotope leaders from across Canada and around the world to Toronto on June 12th and 13th for two days of insightful discussions, presentations, and networking. For more information on the Canadian Radiotheranostics Leaders’ Summit 2025, and to register, visit our website: https://lnkd.in/g6U9HBSE

#ICYMI Don't forget to register to join us next Tuesday for a virtual signing event hosted in collaboration with the International Atomic Energy Agency (IAEA) in support of the Rays of Hope initiative. We're excited to share the next steps in the ongoing collaboration between the CNIC and the IAEA and hope you'll join us to learn more about our efforts, and to hear from the group of distinguished Canadian and International leaders who will join us for the event. Register today! https://lnkd.in/ersQVadH

We're excited to invite you to join us next Tuesday for a virtual signing event hosted in collaboration with the International Atomic Energy Agency (IAEA) in support of the Rays of Hope initiative. This event will showcase the next steps in the ongoing collaboration between the CNIC and the IAEA and will feature leaders from across Canada and the international community. Register now to join us for this important event: https://lnkd.in/ersQVadH

#ICYMI Did you know that Ontario recently became the first province in Canada to offer public reimbursement of PLUVICTO, a targeted radioligand therapy for patients with advanced prostate cancer which utilizes lutetium-177. This is an important first step in ensuring that patients across Canada have access to innovative and life-changing drugs that utilize medical isotopes. The CMIE’s work supports both existing and emerging companies that are leading research and innovation efforts to help produce more life-saving medical isotopes and radiopharmaceuticals to support patients and families around the world. Read more about our work here: https://lnkd.in/d_VHNe_R

We're excited to introduce the distinguished panelists for Monday's webinar, "Radiopharmaceutical Drug Development in Canada", hosted in partnership with the Canadian Medical Isotope Ecosystem. These leaders will share their unique insights and perspectives on the process of developing new radiopharmaceuticals in Canada, the manufacturing and commercialization landscape, and the difficulties associated with navigating regulatory filings with Health Canada and the FDA. Register now to join us next Monday, February 24th at 11am EST. For more information about the panelists and to register, click here: https://lnkd.in/gxFssUQr

Don’t forget to register for “Radiopharmaceutical Drug Development in Canada”, our upcoming webinar with the Canadian Nuclear Isotope Council. Join us on February 24th to hear from our panel of distinguished leaders from across Canada’s radiopharmaceutical sector as they share their perspectives on the manufacturing, commercialization, and regulatory landscape in Canada. Register here: https://lnkd.in/gxFssUQr

We would like to take a moment to recognize and thank our sponsors for their support of the Canadian Radiotheranostics Leaders’ Summit 2025. The success of the Leaders' Summit 2025 depends on the financial support from our sponsors to support our vision. Thank you for your continued support! For more information about the Leaders' Summit 2025, including sponsorship opportunities, click here: https://lnkd.in/g6U9HBSE

Register today for our upcoming webinar, “Radiopharmaceutical Drug Development in Canada”! The webinar will feature a panel of leaders from across the isotope and radiopharmaceutical sectors sharing their expertise and perspectives on the manufacturing, commercialization and regulatory landscape in Canada. Learn more and register here: https://lnkd.in/gxFssUQr